The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $61.42

Today's change-0.24 -0.39%
Updated January 19 3:27 PM EST. Delayed by at least 15 minutes.
 

AbbVie Inc

NYSE: ABBV
Last

(U.S.) $61.42

Today's change-0.24 -0.39%
Updated January 19 3:27 PM EST. Delayed by at least 15 minutes.

AbbVie Inc crosses below 50-day moving average

AbbVie Inc is lower today, dropping (U.S.)$0.24 or 0.39% to (U.S.)$61.42 and crossing below its 50-day moving average. Over the last five days, shares are unchanged, but have gained 11.69% over the last 52 weeks. This security has underperformed the S&P 500 by 8.65% during the last year.

Key company metrics

  • Open(U.S.) $61.45
  • Previous close(U.S.) $61.66
  • High(U.S.) $61.88
  • Low(U.S.) $61.12
  • Bid / Ask(U.S.) $61.42 / (U.S.) $61.43
  • YTD % change-1.92%
  • Volume4,203,416
  • Average volume (10-day)7,709,521
  • Average volume (1-month)7,318,394
  • Average volume (3-month)7,483,673
  • 52-week range(U.S.) $51.60 to (U.S.) $68.12
  • Beta1.59
  • Trailing P/E16.52×
  • P/E 1 year forward12.79×
  • Forward PEG0.83×
  • Indicated annual dividend(U.S.) $2.56
  • Dividend yield4.17%
  • Trailing EPS(U.S.) $3.72
Updated January 19 3:27 PM EST. Delayed by at least 15 minutes.
S&P TSX0.13%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue6,4326,4525,9586,400
Total other revenue--------
Total revenue6,4326,4525,9586,400
Gross profit4,9245,0294,6274,925
Total cost of revenue1,5081,4231,3311,475
Total operating expense4,0714,0653,6804,287
Selling / general / administrative1,3811,4661,3551,737
Research & development1,1061,124946891
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)807049184
Other operating expenses, total------0
Operating income2,3612,3872,2782,113
Interest income (expense), net non-operating-271-245-215-208
Gain (loss) on sale of assets--------
Other--------
Income before tax2,0142,0961,7761,924
Income after tax1,5981,6101,3541,517
Income tax, total416486422407
Net income1,5981,6101,3541,517
Total adjustments to net income--------
Net income before extra. items1,5981,6101,3541,517
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,5981,6101,3541,517
Inc. avail. to common incl. extra. items1,5981,6101,3541,517
Diluted net income1,5981,6101,3541,517
Dilution adjustment--------
Diluted weighted average shares1,6401,6321,6251,643
Diluted EPS excluding extraordinary itemsvalue per share0.970.990.830.92
Dividends per sharevalue per share0.570.570.570.57
Diluted normalized EPSvalue per share1.021.030.861.01